REVIEW PAPER
Evaluation of internal exposure of nuclear medicine staff working with radioiodine in Poland
 
More details
Hide details
1
Central Laboratory for Radiological Protection, Warsaw, Poland
 
 
Online publication date: 2023-09-28
 
 
Corresponding author
Grażyna Krajewska   

Central Laboratory for Radiological Protection, Konwaliowa 7, 03-194 Warsaw, Poland
 
 
Int J Occup Med Environ Health 2023;36(5):587–595
 
KEYWORDS
TOPICS
ABSTRACT
The iodine-131 (I-131) content in the thyroid of staff members working with this radionuclides has been measured with about 500 employees in about 25 hospital’s departments of nuclear medicine performing therapy and diagnosis of thyroid disease in Poland. The measurements were performed with portable detection unit for in situ measurements of radioiodine. This is consist with scintillation detector sodium iodine activated by thallium (NaI(Tl)) – battery-powered and portable tube base Multichannel Analyzer Canberra UniSPEC. Based on direct measurements of the iodine content, the effective dose equivalent for workers due to inhalation of I-131 was estimated. All individuals actively working with iodine show measurable amounts of this isotopes in their thyroids. The average measured activity in the thyroid of the nuclear medicine staff was found to be equal at average 550 Bq within the range 70 Bq–2.5 kBq. There is no apparent correlation between the measured I-131 levels and risk categories. Nevertheless the technical and nuclear medicine staff show higher I-131 thyroid level comparing to hospital services staff. Calculated maximum committed effective dose for particular exposed person is <10% of 20 mSv/year. Int J Occup Med Environ Health. 2023;36(5):587–95
eISSN:1896-494X
ISSN:1232-1087